BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

LD-2 disclosure · 4th Quarter - Termination

GLOBAL BLOOD THERAPEUTICS

via GLOBAL BLOOD THERAPEUTICS

4th Quarter (Oct 1 - Dec 31) · 2022Posted Jan 19, 2023Filing document ↗LDA record ↗

Expenses$290Kself-filed spend

Client

Name: GLOBAL BLOOD THERAPEUTICS
Location: California · United States of America

Registrant

Firm: GLOBAL BLOOD THERAPEUTICS
Description: biopharmaceutical company
Location: South San Francisco, California, United States of America

Lobbying activities

1 issue

Health Issues
Sickle Cell Disease Education and Advocacy.
LobbyistsAARON KRUPP
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

GLOBAL BLOOD THERAPEUTICS — Lobbying — Receipts Report